Co-Diagnostics holders exercise 1,702,362 warrants at USD 1.57 per share in inducement deal
CODX•New warrants and expected proceeds
The transaction includes issuance of new warrants for 3,404,724 shares at USD 1.56, exercisable only after required Nasdaq stockholder approval.
Gross proceeds are expected at about USD 2.67 million, with closing targeted for about Aug. 3, 2026.
The shares underlying the existing warrants are already registered; a resale registration statement is required for shares underlying the new warrants.
Inducement deal for warrant exercise
Co-Diagnostics entered an inducement deal for holders to cash-exercise existing warrants for 1,702,362 shares at USD 1.57 each.
